glp 1 agonist microdosing GLP-1s: Reduce Inflammation, Support Cognitive Health, and More — Dr. Michelle Weiner at NeuroPain Health GLP-1 Microdosing Explained - Gift

Tirzepatide is a dual GIP/GLP-1 receptor agonist that simultaneously occupies GLP-1 and GIP receptors

doi: 10.1038/nm.2219 54 DuricV.BanasrM.StockmeierC

Drugs 78(11):11131132 [DOI] [PMC free article] [PubMed] [Google Scholar] dAquino AI, Maikawa CL, Nguyen LT, Lu K, Hall IA, Jons CK, et al (2023) Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management

GLP-1RA also significantly improved weight management for type 2 diabetes, with CagriSema performing the best on weight loss

Innovation : The current AOM pipeline comprises 157 clinical-stage assets, including 7 in phase 3, and spans over 60 mechanisms of action, while 43% of all AOM assets are oral therapies (see Figure 2)

Overeating can lead to weight gain if the person consumes more calories than they burn off